Lisanti Capital Growth’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-35,700
| Closed | -$1.95M | – | 122 |
|
|
2025
Q3 | $1.95M | Buy |
35,700
+4,640
| +15% | +$232K | 0.48% | 80 |
|
|
2025
Q2 | $1.65M | Buy |
+31,060
| New | +$1.58M | 0.46% | 80 |
|
|
2024
Q4 | – | Sell |
-15,260
| Closed | -$1.04M | – | 120 |
|
|
2024
Q3 | $1.04M | Buy |
+15,260
| New | +$861K | 0.26% | 104 |
|
|
2024
Q2 | – | Sell |
-11,110
| Closed | -$767K | – | 122 |
|
|
2024
Q1 | $767K | Sell |
11,110
-170
| -2% | -$10.8K | 0.19% | 111 |
|
|
2023
Q4 | $834K | Sell |
11,280
-9,440
| -46% | -$619K | 0.2% | 116 |
|
|
2023
Q3 | $1.41M | Sell |
20,720
-52,810
| -72% | -$4.48M | 0.22% | 111 |
|
|
2023
Q2 | $6.9M | Sell |
73,530
-15,915
| -18% | -$1.24M | 0.96% | 39 |
|
|
2023
Q1 | $6.07M | Buy |
89,445
+37,425
| +72% | +$2.41M | 0.85% | 49 |
|
|
2022
Q4 | $2.58M | Buy |
+52,020
| New | +$2.13M | 0.35% | 99 |
|
|
2022
Q3 | – | Sell |
-46,955
| Closed | -$1.85M | – | 114 |
|
|
2022
Q2 | $1.85M | Buy |
+46,955
| New | +$2.51M | 0.25% | 97 |
|
|
2021
Q1 | – | Sell |
-13,580
| Closed | -$1.8M | – | 147 |
|
|
2020
Q4 | $1.8M | Buy |
+13,580
| New | +$1.64M | 0.25% | 108 |
|
|
2019
Q3 | – | Sell |
-18,800
| Closed | -$2.22M | – | 105 |
|
|
2019
Q2 | $2.22M | Buy |
18,800
+6,015
| +47% | +$606K | 0.72% | 55 |
|
|
2019
Q1 | $1.11M | Buy |
12,785
+1,380
| +12% | +$117K | 0.39% | 90 |
|
|
2018
Q4 | $720K | Buy |
+11,405
| New | +$783K | 0.29% | 92 |
|
|
2018
Q3 | – | Sell |
-22,035
| Closed | -$1.32M | – | 135 |
|
|
2018
Q2 | $1.32M | Buy |
+22,035
| New | +$1.19M | 0.5% | 82 |
|
|
2017
Q4 | – | Sell |
-66,252
| Closed | -$3.12M | – | 117 |
|
|
2017
Q3 | $3.12M | Buy |
66,252
+16,145
| +32% | +$650K | 1.96% | 7 |
|
|
2017
Q2 | $1.77M | Buy |
50,107
+16,022
| +47% | +$495K | 1.18% | 29 |
|
|
2017
Q1 | $805K | Buy |
+34,085
| New | +$675K | 1.15% | 36 |
|
|
2014
Q4 | – | Sell |
-22,975
| Closed | -$445K | – | 94 |
|
|
2014
Q3 | $445K | Sell |
22,975
-29,860
| -57% | -$547K | 0.22% | 93 |
|
|
2014
Q2 | $900K | Sell |
52,835
-11,380
| -18% | -$157K | 0.4% | 85 |
|
|
2014
Q1 | $910K | Buy |
+64,215
| New | +$867K | 0.39% | 85 |
|
Other funds holding EXAS
HI
PCM
FCM
DKCM
Lisanti Capital Growth's EXAS Position: Q4 2025 in Review
Lisanti Capital Growth sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 35,700 shares — an estimated $1.95M sold.
Lisanti Capital Growth first reported a position in EXAS in Q1 2014 and held it in 21 quarters. The position peaked at $6.9M in Q2 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.
- Lisanti Capital Growth reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
- Lisanti Capital Growth sold 35,700 Exact Sciences shares in Q4 2025, an estimated $1.95M.
- Lisanti Capital Growth first reported a position in Exact Sciences in Q1 2014 and held it in 21 quarters.
- Lisanti Capital Growth's Exact Sciences position peaked at $6.9M in Q2 2023.
- 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.
Based on Lisanti Capital Growth's 13F filing for Q4 2025, filed 9 Feb 2026.